Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction

AIMS: While mineralocorticoid receptor antagonists (MRAs) have been shown to benefit patients with reduced left ventricular ejection fraction (LVEF), spironolactone did not reduce the primary endpoint of cardiovascular death, heart failure hospitalization, or aborted cardiac arrest in patients with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J
Autors principals: Solomon, Scott D., Claggett, Brian, Lewis, Eldrin F., Desai, Akshay, Anand, Inder, Sweitzer, Nancy K., O'Meara, Eileen, Shah, Sanjiv J., McKinlay, Sonja, Fleg, Jerome L., Sopko, George, Pitt, Bertram, Pfeffer, Marc A.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2016
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4751235/
https://ncbi.nlm.nih.gov/pubmed/26374849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv464
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars